Publicacions en col·laboració amb investigadors/es de Hospital Universitario Marqués de Valdecilla (14)

2023

  1. Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III

    Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 67-73

2022

  1. Amylin serum levels are upregulated in patients with systemic lupus erythematosus

    Clinical and Experimental Rheumatology, Vol. 40, Núm. 7, pp. 1378-1384

  2. Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis

    Arthritis Research and Therapy, Vol. 24, Núm. 1

  3. Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease

    Clinical and translational gastroenterology, Vol. 13, Núm. 6, pp. e00500

  4. Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus

    Frontiers in Immunology, Vol. 13

  5. The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis

    Arthritis Research and Therapy, Vol. 24, Núm. 1

2021

  1. Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Arthritis Care and Research, Vol. 73, Núm. 11, pp. 1590-1596

  2. Higher prevalence and degree of insulin resistance in patients with rheumatoid arthritis than in patients with systemic lupus erythematosus

    Journal of Rheumatology, Vol. 48, Núm. 3

  3. Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity

    Rheumatology (Oxford, England), Vol. 60, Núm. 5, pp. 2296-2306

2020

  1. Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 917-924

  2. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis

    Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2847-2856

  3. Insulin resistance in non-diabetes patients with spondyloarthritis

    Scandinavian Journal of Rheumatology, pp. 1-8

  4. Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus

    Therapeutic Advances in Musculoskeletal Disease, Vol. 12

  5. The number of traditional cardiovascular risk factors is independently correlated with disease activity in patients with psoriatic arthritis

    Medicina (Lithuania), Vol. 56, Núm. 8, pp. 1-9